Identification of Dopamine “D3′’ and “D4′’ Binding Sites, Labelled with [3H]2‐Amino‐6,7‐Dihydroxy‐ 1,2,3,4‐ Tetrahydronaphthalene, as High Agonist Affinity States of the D1 and D2 Dopamine Receptors, Respectively

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Journal of Neurochemistry

• Publication date

  1986-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1471-4159.1986.tb00618.xPMID 2936868
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [3H]205-501, a Non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptors

  2005cited by this paper
• Three classes of dopamine receptor (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-domperidone

  2004cited by this paper
• Characterization of the Binding of 3H-2-Amino-6,7-dihydroxy-tetrahydronaphthalene (ADTN) to Rat Striatal Membranes: Similarities and Discrepancies between D1 and D3 as well as D2 and D4 Dopamine Receptors

  1986cited by this paper
• Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.

  1985cited by this paper
• Dopamine D2 Receptors in the Anterior Pituitary: A Single Population Without Reciprocal Antagonist/Agonist States

  1985cited by this paper
• Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.

  1985cited by this paper
• Conversion of dopamine D1 receptors from high to low affinity for dopamine.

  1985cited by this paper
• The ternary complex model. Its properties and application to ligand interactions with the D2-dopamine receptor of the anterior pituitary gland.

  1984cited by this paper
• Criteria for receptor sites in binding studies.

  1984cited by this paper
• Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.

  1984cited by this paper
• Dopaminergic 3H-agonist receptors in rat brain. New evidence on localization and pharmacology.

  1984cited by this paper
• Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide.

  1984cited by this paper
• Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.

  1984cited by this paper
• Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.

  1984cited by this paper
• Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state.

  1983cited by this paper
• Dopaminergic D-3 binding sites are not presynaptic autoreceptors

  1983cited by this paper
• Ascorbic acid and the binding of DA agonists to neostriatal membrane preparations.

  1983cited by this paper
• SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.

  1983cited by this paper
• Mesulergine and its 1,20-N,N-bidemethylated metabolite interact directly with D1- and D2-receptors.

  1983cited by this paper
• [3H]dopamine binds to D-1 and D-2 receptors in rat striatum.

  1983cited by this paper
• The classification of dopamine receptors: relationship to radioligand binding.

  1983cited by this paper
• Cholecystokinin octapeptide levels in rat brain are changed after subchronic neuroleptic treatment.

  1983cited by this paper
• Dopamine receptors re-explained

  1983cited by this paper
• Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4- tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neuroleptics

  1982cited by this paper
• Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor.

  1982cited by this paper
• 3H-dopamine binding to rat striatal D-2 and D-3 sites: enhancement by magnesium and inhibition by guanine nucleotides and sodium.

  1982cited by this paper
• Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide.

  1982cited by this paper
• Dopamine receptors in rat brain regions. Optimal conditions for 3H-agonist binding, pH dependency and lack of inhibition by ascorbic acid.

  1982influential reference
• Dopamine receptor of the porcine anterior pituitary gland. Evidence for two affinity states discriminated by both agonists and antagonists.

  1982cited by this paper
• Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina.

  1982cited by this paper
• Ascorbic acid enables reversible dopamine receptor 3H-agonist binding.

  1981cited by this paper
• Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor

  1981cited by this paper
• The role of hormone receptors and GTP-regulatory proteins in membrane transduction

  1980cited by this paper
• A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor.

  1980cited by this paper
• Brain dopamine receptors.

  1980cited by this paper
• Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.

  1979cited by this paper
• Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity.

  1979cited by this paper
• Multiple receptors for dopamine

  1979cited by this paper
• In vitro acetylcholine release from rat caudate nucleus as a new model for testing drugs with dopamine-receptor activity

  1979cited by this paper
• The central effects of a novel dopamine agonist.

  1978cited by this paper
• Dopamine receptor binding: specificity, localization and regulation by ions and guanyl nucleotides.

  1978cited by this paper
• A simple ultrasensitive method for the assay of cyclic AMP and cyclic GMP in tissues.

  1976cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper
• Radioimmunoassay for the measurement of adenosine 3',5'-cyclic phosphate.

  1969cited by this paper
• THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

  1949cited by this paper
• pAx and competitive drug antagonism.

  1949cited by this paper

• Ligands for the dopamine D 2-like receptors

  2017cites this paper
• Reports Quantification of Optic Nerve Blood Flow Changes Using Magnetic Resonance Imaging

  2005cites this paper
• SDZ GLC 756, a novel octahydrobenzo[g]quinoline derivative exerts opposing effects on dopamine D1 and D2 receptors

  2005cites this paper
• Dual 5-HT1A agonists and 5-HT re-uptake inhibitors by combination of indole-butyl-amine and chromenonyl-piperazine structural elements in a single molecular entity.

  2004cites this paper
• Synthesis and structure--activity relationship in a class of indolebutylpiperazines as dual 5-HT(1A) receptor agonists and serotonin reuptake inhibitors.

  2004cites this paper
• Indolebutylamines as selective 5-HT(1A) agonists.

  2004cites this paper
• Ligands for the dopamine D2-like receptors

  1998cites this paper
• Affinity for dopamine D2, D3, and D4 receptors of 2-aminotetralins. Relevance of D2 agonist binding for determination of receptor subtype selectivity.

  1996cites this paper
• Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.

  1995cites this paper
• Quantification of optic nerve blood flow changes using magnetic resonance imaging.

  1995cites this paper
• Multivariate QSAR and Computational Chemistry: A Novel Receptor Model of the D1 Agonist Binding Site

  1994cites this paper
• The pharmacology of SDZ EAA 494, a competitive NMDA antagonist.

  1994cites this paper
• Synthesis and pharmacological evaluation of the enantiomers of the dopamine autoreceptor agonist PD 135385

  1993cites this paper
• 4-Aryltetrahydropyridines as selective σ ligands

  1993cites this paper
• Structural modification patterns from agonists to antagonists and their application to drug design--a new serotonin (5-HT3) antagonist series.

  1993cites this paper
• Synthesis and dopaminergic activity of some 3-(1,2,3,6-tetrahydro-1-pyridylalkyl)indoles. A novel conformational model to explain structure-activity relationships.

  1992cites this paper
• Hallervorden-Spatz syndrome and brain iron metabolism.

  1991cites this paper
• Effect of ferric nitrilotriacetate on rostral mesencephalic cells

  1991cites this paper
• Novel 4,5,6,7-tetrahydrobenzothiazole dopamine agonists display very low stereoselectivity in their interaction with dopamine receptors.

  1991cites this paper
• Dopamine autoreceptor agonists as potential antipsychotics. 3.6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine.

  1991cites this paper
• Mono- and divalent cations modulate the affinities of brain D1 and D2 receptors for dopamine by a mechanism independent of receptor coupling to guanyl nucleotide binding proteins

  1989cites this paper
• Characterization of unique ADTN-catecholamine binding sites in the iris root-ciliary body of rabbits.

  1989cites this paper
• Dopamine Receptors in the Central Nervous System

  1989cites this paper
• Localization and pharmacology of some dopamine receptor complexes in the striatum and the pituitary gland: synaptic and son-synaptic communication.

  1988cites this paper
• 3- and 4-O-sulfoconjugated and methylated dopamine: highly reduced binding affinity to dopamine D2 receptors in rat striatal membranes

  1988cites this paper
• Modulation of dopamine receptors by thyrotropin-releasing hormone in the rat brain.

  1987cites this paper
• D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications.

  1987cites this paper
• Binding of 3H-spiperone and 3H-(−)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands

  1987cites this paper
• Affinity Shifts Induced by Cations Do Not Reliably Predict the Agonistic or Antagonistic Nature of Ligands at Brain Dopamine Receptors

  1987cites this paper
• The D-1 Dopamine Receptor and the Search for its Functional Role: From Neurochemistry to Behaviour

  1987cites this paper
• Dopamine receptors and the dopamine hypothesis of schizophrenia

  1987cites this paper
• Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications

  1987cites this paper
• Haloperidol‐succinylglycyl[125I]iodotyrosine, a novel iodinated ligand for dopamine D2 receptors

  1987cites this paper